Corrigendum: An Acute, Double-Blind, Placebo-Controlled Cross-over Study of 320 mg and 640 mg Doses of Bacopa monnieri (CDRI 08) on Multitasking Stress Reactivity and Mood

The above article published in Phytotherapy Research (Benson et al., 2014) contains an important methodological mistake/omission relating to KeenMind Bacopa monniera extract (CDRI 08; Flordis Pty Ltd) which the authors consider it is important to bring to the attention of the readers.

In the ‘Study design and treatment conditions’ part of the Methods section, the authors stated: ‘This patented extract of Bacopa monniera is prepared from stems, leaves and roots of a cultured variety of Bacopa monniera (collected from West Bengal) and extracted with 50% ethanol.’ The concentration of the extraction solvent in manufacturing has been stated incorrectly and the actual concentration was 75 % ethanol.

We apologize for this error and for any inconvenience caused. The authors relied on the information supplied to them by the manufacturers, which was incorrect.